Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring
The need for mycophenolic acid (MPA) monitoring is still under discussion. Key issues for the PK/PD relationships of this drug are: the role of metabolites, the usefulness of AUC versus predose levels, and the need to monitor the free concentration of MPA (f-MPA). Recent advances have revealed that,...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 2000
|
| In: |
Therapeutic drug monitoring
Year: 2000, Volume: 22, Issue: 1, Pages: 20-26 |
| ISSN: | 1536-3694 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/drug-monitoring/Fulltext/2000/02000/Pharmacokinetic_and_Metabolic_Investigations_of.4.aspx
|
| Author Notes: | Michael Oellerich, Maria Shipkova, Ekkehard Schütz, Eberhard Wieland, Lute Weber, Burkhard Tönshoff, Victor W. Armstrong |
| Summary: | The need for mycophenolic acid (MPA) monitoring is still under discussion. Key issues for the PK/PD relationships of this drug are: the role of metabolites, the usefulness of AUC versus predose levels, and the need to monitor the free concentration of MPA (f-MPA). Recent advances have revealed that, in addition to 7-O-MPAG, three additional MPA metabolites are present in the plasma of transplant recipients. One of these metabolites (M-2), identified as an acyl glucuronide of MPA, was found to inhibit IMPDH-II in vitro. This active metabolite was also found to cross-react in the Emit assay for MPA. In an ongoing multicenter study, the authors are evaluating the relevance of monitoring total (t-MPA) and free mycophenolic acid (f-MPA) in pediatric renal transplant recipients. |
|---|---|
| Item Description: | Der Verfasser "Lutz Weber" wurde in der Verfasserliste falsch geschrieben Gesehen am 26.01.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1536-3694 |